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Abstract While tuberculosis (TB) is a risk factor in HIV-1-infected individuals, the mechanisms by
which Mycobacterium tuberculosis (Mtb) worsens HIV-1 pathogenesis remain scarce. We showed
that HIV-1 infection is exacerbated in macrophages exposed to TB-associated microenvironments
due to tunneling nanotube (TNT) formation. To identify molecular factors associated with TNT
function, we performed a transcriptomic analysis in these macrophages, and revealed the up-
regulation of Siglec-1 receptor. Siglec-1 expression depends on Mtb-induced production of type I
interferon (IFN-I). In co-infected non-human primates, Siglec-1 is highly expressed by alveolar
macrophages, whose abundance correlates with pathology and activation of IFN-I/STAT1 pathway.
Siglec-1 localizes mainly on microtubule-containing TNT that are long and carry HIV-1 cargo. Siglec-
1 depletion decreases TNT length, diminishes HIV-1 capture and cell-to-cell transfer, and abrogates
the exacerbation of HIV-1 infection induced by Mtb. Altogether, we uncover a deleterious role for
Siglec-1 in TB-HIV-1 co-infection and open new avenues to understand TNT biology.
Introduction
Co-infection with Mycobacterium tuberculosis (Mtb) and the human immunodeficiency virus (HIV-1),
the agents of tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS), respectively, is a
major health issue. Indeed, TB is the most common illness in HIV-1-infected individuals, about 55%
of TB notified patients are also infected with HIV-1, and about a fifth of the TB death toll occurs in
HIV-1 co-infected individuals (WHO health report 2017). Clinical studies evidence a synergy between
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these two pathogens, which is associated with a spectrum of aberration in immune function
(Esmail et al., 2018). Yet, while progress has been made towards understanding how HIV-1 enhan-
ces Mtb growth and spread, the mechanisms by which Mtb exacerbates HIV-1 infection require fur-
ther investigation (Bell and Noursadeghi, 2018; Deffur et al., 2013; Diedrich and Flynn, 2011).
Besides CD4+ T cells, macrophages are infected by HIV-1 in humans and by the simian immuno-
deficiency virus (SIV), the most closely related lentivirus to HIV, in non-human primates (NHP)
(Cribbs et al., 2015; Rodrigues et al., 2017). Recently, using a humanized mouse model, macro-
phages were shown to sustain HIV-1 infection and replication, even in the absence of T cells
(Honeycutt et al., 2017; Honeycutt et al., 2016). This is in line with several studies characterizing
tissue macrophages, such as alveolar, microglia and gut macrophages, as reservoirs in HIV-1 patients
undergoing antiretroviral therapy (Ganor et al., 2019; Jambo et al., 2014; Mathews et al., 2019;
Sattentau and Stevenson, 2016).
Macrophages are key host cells for Mtb (O’Garra et al., 2013; VanderVen et al., 2016). We
recently reported the importance of macrophages in HIV-1 exacerbation within the TB co-infection
context (Souriant et al., 2019). Using relevant in vitro and in vivo models, we showed that TB-associ-
ated microenvironments activate macrophages towards an M(IL-10) profile, distinguished by a
CD16+CD163+MerTK+ phenotype. Acquisition of this phenotype is dependent on the IL-10/STAT3
signaling pathway (Lastrucci et al., 2015). M(IL-10) macrophages are highly susceptible not only to
Mtb infection (Lastrucci et al., 2015), but also to HIV-1 infection and spread (Souriant et al., 2019).
At the functional level, we demonstrated that TB-associated microenvironments stimulate the forma-
tion of tunneling nanotubes (TNT), membranous channels connecting two or more cells over short to
long distances above substrate. TNT are subdivided in two classes based on their thickness and
cytoskeleton composition: ‘thin’ TNT (<0.7 mm in diameter) containing F-actin, and ‘thick’ TNT (>0.7
mm in diameter) are enriched in F-actin and microtubules (MT) (Souriant et al., 2019). Thick TNT are
functionally distinguished by the transfer of large organelles, such as lysosomes and mitochondria
(Dupont et al., 2018; Eugenin et al., 2009; Hashimoto et al., 2016). While the contribution for
each TNT class to HIV-1 pathogenesis has not been explored (Dupont et al., 2018; Eugenin et al.,
2009; Hashimoto et al., 2016), we reported that total inhibition of TNT formation in M(IL-10) mac-
rophages resulted in the abrogation of HIV-1 exacerbation induced by Mtb (Souriant et al., 2019).
Factors influencing TNT function in M(IL-10) macrophages remain unknown at large.
In this study, global mapping of the M(IL-10) macrophage transcriptome revealed Siglec-1
(CD169, or sialoadhesin) as a potential factor responsible for HIV-1 dissemination in the co-infection
context with TB. As a type-I transmembrane lectin receptor, Siglec-1 possesses a large extracellular
domain composed of 17 immunoglobulin-like domains, including the N-terminal V-set domain, which
allows the trans recognition of terminal a2,3-linked sialic acid residues in O- and N-linked glycans
and glycolipids, such as those surface-exposed in HIV-1 and SIV particles (Izquierdo-Useros et al.,
2012a; Puryear et al., 2012). While Siglec-1 has yet to be implicated in the TB context, it is clearly
involved in the pathogenesis of HIV-1, SIV and other retroviruses (Martinez-Picado et al., 2017).
Siglec-1 is mainly expressed in myeloid cells (e.g. macrophages and dendritic cells) and participates
in HIV-1 transfer from myeloid cells to T cells, as well as in the initiation of virus-containing compart-
ment (VCC) formation in macrophages (Izquierdo-Useros et al., 2012a; Izquierdo-Useros et al.,
2012b; Puryear et al., 2013; Puryear et al., 2012), and in the viral dissemination in vivo
(Akiyama et al., 2017; Izquierdo-Useros et al., 2012a; Sewald et al., 2015). Indeed, HIV-1 and
other retroviruses have evolved the capacity to hijack the immune surveillance and housekeeping
immunoregulatory functions of Siglec-1 (Izquierdo-Useros et al., 2014; O’Neill et al., 2013). Here,
we investigate how Siglec-1 expression is induced by TB, and the role it has in the capture and trans-
fer of HIV-1 by TB-induced M(IL-10) macrophages, in particular in the context of TNT.
Results
Tuberculosis-associated microenvironments induce Siglec-1 in
macrophages
TB-induced M(IL-10) macrophages are highly susceptible to HIV-1 infection and spread
(Souriant et al., 2019). To assess the global gene expression landscape in these cells, we performed
a genome-wide transcriptome analysis (GEO submission GSE139511). To this end, we employed our
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published in vitro model (Lastrucci et al., 2015), which relies on the use of conditioned medium
from either mock- (cmCTR) or Mtb-infected (cmMTB) human macrophages. As we described and
observed before and herein, cmMTB-treated cells were positive for the M(IL-10) markers (CD16+-
CD163+MerTK+ and phosphorylated STAT3), and displayed a high rate of HIV-1 infection, as com-
pared to those treated with cmCTR (Lastrucci et al., 2015). A distinct 60 gene-transcript signature
was defined in cmMTB-treated cells, using a combination of the expression level, statistical filters
and hierarchical clustering; 51 genes were up-regulated and nine genes were down-regulated in
cmMTB- compared to cmCTR-treated cells (Figure 1A). We compared expression data of cmMTB-
and cmCTR-treated cells to public genesets available from MSigDB (Broad Institute) using the gene
set enrichment analysis (GSEA) algorithm (Subramanian et al., 2005). As shown in Figure 1—figure
supplement 1A, a significant fraction of genes that were up-regulated in response to interferon
(IFN) type I (e.g. IFNa) and II (i.e. IFNg), were also found, as a group, significantly up-regulated in
cmMTB-treated cells in comparison to control samples (FDR q-value:<10-3). IFN-stimulated genes
(ISG) usually exert antiviral activities (McNab et al., 2015; Schneider et al., 2014) and cannot be
inferred as obvious candidates to facilitate HIV-1 infection. However, among this ISG signature, the
up-regulation of Siglec-1 (7.4-fold, adjusted p-value of 0.0162) in cmMTB-treated cells captured our
attention due to its known role in HIV-1 pathogenesis (Izquierdo-Useros et al., 2014; O’Neill et al.,
2013). We confirmed a high Siglec-1 expression in cmMTB-treated macrophages at the mRNA
(Figure 1B), intracellular and cell-surface protein (Figure 1C and Figure 1—figure supplement 1B–
D) levels. This effect was superior to the level obtained in HIV-1-infected cells (Figure 1—figure sup-
plement 1E). Particularly, cmMTB-treated macrophages displayed high density of Siglec-1 surface
expression applying a quantitative FACS assay that determines the absolute number of Siglec-1 anti-
body binding sites per cell (Figure 1D).
These data indicate that Siglec-1 is highly expressed in human macrophages exposed to TB-asso-
ciated microenvironments and potentially in the context of TB-HIV co-infection.
Siglec-1+ alveolar macrophage abundance correlates with pathology in
co-infected primates
NHP has been an invaluable in vivo model to better understand the role of macrophages in SIV/HIV
pathogenesis (Merino et al., 2017). Considering Siglec-1 binds sialylated lipids present in the
envelop of HIV-1 and SIV (Izquierdo-Useros et al., 2012a; Puryear et al., 2012), we examined the
presence of Siglec-1 positive alveolar macrophages in lung biopsies obtained from different NHP
groups: (i) co-infected with Mtb (active or latent TB) and SIV, (ii) mono-infected with Mtb (active or
latent TB), (iii) mono-infected with SIV, and (iv) healthy (Supplementary file 1-Table S1, Figure 1—
figure supplement 2A; Cai et al., 2015; Kuroda et al., 2018; Souriant et al., 2019). Histological
immuno-staining confirmed the presence of Siglec-1+ alveolar macrophages in the lungs of healthy
NHP (Figure 1E–F and Figure 1—figure supplement 2A), and revealed its significant increase in
NHP mono-infected with either Mtb or SIV (Figure 1E–F and Figure 1—figure supplement 2A).
Strikingly, we noticed a massive abundance of these cells in co-infected NHP (Figure 1E–F and Fig-
ure 1—figure supplement 2A). Concerning the overall abundance of Siglec-1+ leukocytes in lungs,
we observed a significant increase in all infected NHP in comparison to healthy, with a higher ten-
dency in active TB or co-infected NHP (Figure 1G and Figure 1—figure supplement 2A). In fact,
the number of Siglec-1+ leukocytes correlated positively with the severity of NHP pathology
(Figure 1H, Supplementary file 1-Table S2). Based on their cell morphology, localization in alveoli,
and co-expression with the macrophage marker CD163 (Figure 1—figure supplement 2A–C),
Siglec-1+ cells were identified as alveolar macrophages.
Collectively, these data show that Siglec-1 is up-regulated in alveolar macrophages in the context
of a retroviral co-infection with active TB.
Siglec-1 expression is dependent on Mtb-induced type I IFN signaling
Siglec-1 is an ISG whose expression is induced by IFN-I in myeloid cells (Hartnell et al., 2001). In
addition to viral infection, IFN-I is also induced in TB and known to mainly play a detrimental role
(McNab et al., 2015; Moreira-Teixeira et al., 2018). Siglec-1 expression has not been described in
the TB context or in co-infection with retroviruses such as SIV or HIV-1, therefore we assessed
whether IFN-I stimulates Siglec-1 expression in TB-associated microenvironments. First, we found
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Figure 1. Tuberculosis-associated microenvironments induce Siglec-1 expression in macrophages. (A–D) For 3 days, human monocytes were
differentiated into macrophages with cmCTR (white) or cmMTB (black) supernatants. (A) Heatmap from a transcriptomic analysis (GEO submission
GSE139511) illustrating the top 60 differentially expressed genes (DEGs) between cmCTR- or cmMTB-cells. Selection of the top DEGs was performed
using an adjusted p-value  0.05, a fold change of at least 2, and a minimal expression of 6 in a log2 scale. Hierarchical clustering was performed using
Figure 1 continued on next page
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that cmMTB contains high amounts of IFN-I compared to cmCTR (Figure 2A). Next, we showed that
recombinant IFN-b significantly increased Siglec-1 cell-surface expression in macrophages, close to
the level induced by cmMTB (Figure 2B). Interestingly, we observed a modest, albeit significant,
induction of Siglec-1 expression in cells treated with interleukin 10 (IL-10), a cytokine we have previ-
ously shown to be abundant in cmMTB (Lastrucci et al., 2015) and that renders macrophages highly
susceptible to HIV-1 infection (Souriant et al., 2019). However, IL-10 depletion had no effect on
Siglec-1 expression by cmMTB-treated cells (Figure 2C). By contrast, blocking the IFN-I receptor
(IFNAR-2) during cmMTB treatment fully abolished the expression of Siglec-1 (Figure 2D and Fig-
ure 1—figure supplement 1D), indicating that IFN-I is the responsible factor for Siglec-1 up-regula-
tion in cmMTB-treated cells.
IFN-I binding to IFNAR leads to the phosphorylation and nuclear translocation of the transcription
factor STAT1, whose role is essential for transcription of ISG (Ivashkiv and Donlin, 2014). We thus
examined the status of STAT1 activation in co-infected NHP lung tissue. Histological staining of serial
sections of co-infected lungs revealed that zones rich in Siglec-1+ leukocytes also exhibited positivity
for nuclear phosphorylated STAT1 (pSTAT1) (Figure 2E), and the abundance of these two markers
strongly correlated with the active status of TB in the different NHP groups (Figure 2F). Moreover,
we found that the majority of Siglec-1+ alveolar macrophages were also positive for nuclear pSTAT1
in the infected NHP groups compared to healthy (Figure 2E and G). In fact, there was a higher num-
ber of pSTAT1+ alveolar macrophages in TB-SIV co-infected lungs when compared to those from
mono-infected NHP and this number directly correlates with the number of Siglec-1+ alveolar macro-
phages (Figure 2G–H).
Altogether, these data demonstrate that Siglec-1 expression in human macrophages is controlled
by IFN-I in a TB-associated microenvironment, and suggest the involvement of the IFN-I/STAT1/
Siglec-1 axis in the pathogenesis of TB and co-infection with retroviruses.
Siglec-1 localization on thick TNT is associated with their length and
HIV-1 cargo
TNT formation is responsible for the increase in HIV-1 spread between human macrophages in TB-
associated microenvironments (Souriant et al., 2019). To investigate whether Siglec-1 expression is
involved in this process, we first examined its localization in the context of TNT formed by cmMTB-
treated cells infected by HIV-1. We observed that Siglec-1 is localized mainly on microtubule (MT)-
positive thick TNT, and not on thin TNT (Figure 3A and Figure 3—video 1). Semi-automatic quanti-
fication of hundreds of TNT showed that about 50% of thick TNT were positive for Siglec-1
(Figure 3B and Figure 3—figure supplement 1A). These TNT exhibited a greater length compared
to those lacking Siglec-1 (Figure 3C). Importantly, unlike thin TNT, HIV-1 viral proteins are found
mainly inside Siglec-1+ thick TNT (Figure 3D–E and Figure 3—video 2). In addition, these thick TNT
Figure 1 continued
the complete linkage method and the Pearson correlation metric with Morpheus (Broad Institute). Interferon-stimulated genes (ISG) are labelled with an
asterisk and Siglec-1 is indicated in red. (B–D) Validation of Siglec-1 expression in cmMTB-treated macrophages. Vertical scatter plots showing the
relative abundance to mRNA (B), median fluorescent intensity (MFI) (C), and mean number of Siglec-1 antibody binding sites per cell (D). Each circle
represents a single donor and histograms median values. (E) Representative immunohistochemical images of Siglec-1 staining (brown) in lung biopsies
of healthy, SIV infected (SIV), active TB (ATB), and co-infected (ATB-SIV) non-human primates (NHP). Scale bar, 100 mm. Insets are 2x zoom. (F) Vertical
Box and Whisker plot indicating the distribution of the percentage of Siglec-1+ alveolar macrophages in lung biopsies from the indicated NHP groups.
Quantification analysis from n = 800 alveolar macrophages grouped from three independent animals per NHP group. (G) Vertical scatter plots
displaying the number of cells that are positive for Siglec-1 per mm2 of lung biopsies from the indicated NHP groups. Each symbol represents a single
animal per NHP group. (H) Correlation between Siglec-1+ cells per mm2 of lung tissue and the pathological score for healthy (white circle), SIV+ (white
triangles), latent (black circle) or active (black square) TB, and SIV+ with latent (grey circle) or active (grey square) TB. Each symbol represents a single
animal per NHP group. Mean value is represented as a black line. Statistical analyses: Two-tailed, Wilcoxon signed-rank test (B–D), Mann-Whitney
unpaired test (F–G), Spearman correlation (H). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. ns: not significant. See Figure 1—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Raw data and statistical analyses supporting Siglec-1 expression in human and non-human primate macrophages exposed to TB-associ-
ated microenvironment.
Figure supplement 1. Tuberculosis-associated microenvironments increase Siglec-1 expression in human macrophages.
Figure supplement 2. Tuberculosis-associated microenvironments increase Siglec-1 expression in non-human primate alveolar macrophages.
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Figure 2. Siglec-1 expression is dependent on Mtb-induced type I IFN signaling. (A) Vertical scatter plot showing the relative abundance of IFN-I in
cmCTR (white) and cmMTB (black) media, as measured indirectly after 24 hr exposure to the HEK-Blue IFN-a/b reporter cell line yielding reporter
activity in units (U) per mL. (B–D) Vertical scatter plots displaying the median fluorescent intensity (MFI) of Siglec-1 cell-surface expression after three
days of monocyte differentiation into macrophages either with cmMTB (black) or cmCTR (white), the indicated recombinant cytokines (B), the presence
Figure 2 continued on next page
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also contained large organelles such as mitochondria (Figure 3F and Figure 3—figure supplement
1B), another characteristic distinguishing thick from thin TNT (Dupont et al., 2018; Onfelt et al.,
2006). In general, we also noticed that the incidence of Siglec-1+ thick TNT between HIV-1 infected
macrophages persisted for more than one week upon HIV-1 infection (Figure 3—figure supplement
1C), suggesting a high degree of stability for these TNT.
These findings reveal a strong localization of Siglec-1 on MT-positive thick TNT that correlates
positively with a greater length and high cargo of HIV-1 or mitochondria, arguing for a functional
capacity of Siglec-1+ TNT to transfer material to recipient cells over long distances.
The Mtb-induced exacerbation of HIV-1 infection and spread in
macrophages requires Siglec-1
To evaluate a functional role for Siglec-1 in the susceptibility of macrophages to HIV-1 infection and
spread induced by TB, Siglec-1 was depleted in cmMTB-treated cells by siRNA-mediated gene
silencing (Figure 4A and Figure 4—figure supplement 1A). While this depletion did not affect the
total number of thick TNT (Figure 4B and Figure 4—figure supplement 1B), we observed a 2-fold
shortening of thick TNT in cells lacking Siglec-1 when compared to control cells (Figure 4C). Then,
we performed a viral uptake assay in these cells using HIV-1-Gag-eGFP virus-like particles (GFP VLP)
lacking the viral envelope glycoprotein but bearing sialylated lipids that interact with Siglec-1 on
myeloid cells (Izquierdo-Useros et al., 2012b; Puryear et al., 2013). We consistently observed
binding of VLP along Siglec-1+ thick TNT (Figure 4—figure supplement 1C). Yet, in the absence of
Siglec-1, we noticed a significant reduction of VLP binding in comparison to control cells (Figure 4—
figure supplement 1D). We confirmed this functional observation using a blocking monoclonal anti-
body against Siglec-1, showing that this receptor is involved in HIV-1 binding in cmMTB-treated cells
(Figure 4—figure supplement 1E).
We then assessed the role of Siglec-1 in HIV-1 transfer between macrophages, as this receptor is
also important for the transfer of the virus to CD4+ T cells (Akiyama et al., 2015; Izquierdo-
Useros et al., 2012a; Puryear et al., 2013). We used an established co-culture system between
cmMTB-treated macrophages that allows the transfer of the viral Gag protein from infected (donor,
Gag+, red) to uninfected (recipient, CellTracker+, green) cells over 24 hr (Souriant et al., 2019; Fig-
ure 4—figure supplement 1F). Of note, since Siglec-1 facilitates the infection of macrophages
(Zou et al., 2011), we used VSV-G pseudotyped viruses to avoid any effect on HIV-1 primo-infection.
Like this, we ensured the viral content was equal in cells at the time of the co-culture despite the
loss of Siglec-1 (Figure 4—figure supplement 1G). The siRNA-mediated depletion of Siglec-1 signif-
icantly diminished the capacity of cmMTB-treated macrophages to transfer HIV-1 to recipient cells
(Figure 4D), indicating that this receptor is involved in the macrophage-to-macrophage viral spread
(Souriant et al., 2019). Intriguingly, there was a decreasing tendency for the capacity of Siglec-1-
depleted cmMTB-treated macrophages to transfer mitochondria to recipient cells compared to con-
trols (Figure 4E and Figure 4—figure supplement 1F), alluding to a possible defect in mechanisms
involved in intercellular material transfer including through thick TNT (Torralba et al., 2016).
Figure 2 continued
of an IL-10 depletion (a-IL-10) or a control (a-IgG) antibodies (C), or the presence of an IFNAR-2 blocking (a-IFNAR) or control (a-IgG) antibodies (D).
(E) Representative serial immunohistochemical images of lung biopsies of a co-infected (ATB-SIV) NHP stained for Siglec-1 (brown, top) and pSTAT1
(brown, bottom). Scale bar, 250 mm. Insets are 10x zooms. (F) Correlation of the percentage of cells positive for Siglec-1 and pSTAT1, as measured per
mm2 of lung tissue from the indicated NHP groups. Mean value is represented as a black line. (G) Representative immunohistochemical images of lung
biopsies from the indicated NHP group stained for pSTAT1 (brown). Arrowheads show pSTAT1-positive nuclei. Scale bar, 500 mm. (H) Upper panel:
Vertical Box and Whisker plot illustrating the percentage of pSTAT1+ alveolar macrophages in lung biopsies from the indicated NHP groups.
Quantification analysis from n = 600 alveolar macrophages grouped from three independent animals per NHP group. Lower panel: Correlation of the
percentage of alveolar macrophages positive for Siglec-1 and pSTAT1, from the indicated NHP groups. Mean value is represented as a black line. (A–
D) Each circle within vertical scatter plots represents a single donor and histograms median value. Statistical analyses: Two-tailed, Wilcoxon signed-rank
test (A–D), Spearman correlation (F, H lower panel), and Mann-Whitney unpaired test (H, upper panel). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
ns: not significant. See Figure 2—source data 1.
The online version of this article includes the following source data for figure 2:
Source data 1. Raw data and statistical analyses supporting that IFN-I induced by M. tuberculosis is responsible for Siglec-1 expression in human and
non-human primate macrophages.
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Figure 3. Siglec-1 localization on thick TNT is associated with their length and HIV-1/mitochondria cargo. (A–F) Human monocytes were differentiated
into macrophages with cmMTB for 3 days, and then infected with HIV-1-ADA strain (unless indicated otherwise) and fixed 3 days post-infection. (A)
Representative immunofluorescence images of cmMTB-treated macrophages infected with HIV-1-ADA, and stained for extracellular Siglec-1 (red),
intracellular tubulin (MT, green) and Wheat Germ Agglutinin (WGA, blue). Inserts are 3x zooms. Red arrowheads show Siglec-1 localization on TNT.
Figure 3 continued on next page
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Remarkably, using replicative HIV-1 ADA strain (Figure 4A), we showed that silencing Siglec-1
expression in cmMTB-treated cells abolished the exacerbation of HIV-1 infection and production, as
well as the enhanced formation of multinucleated giant cells (MGC) (Figure 4F–G), which are patho-
logical hallmarks of HIV-1 infection of macrophages (Vérollet et al., 2015; Vérollet et al., 2010).
These results determine that TB-induced Siglec-1 expression plays a key part in HIV-1 uptake and
efficient cell-to-cell transfer, resulting in the exacerbation of HIV-1 infection and production in M(IL-
10) macrophages.
Discussion
In this study, we investigated potential mechanisms by which Mtb exacerbates HIV-1 infection in
macrophages, and uncovered a deleterious role for Siglec-1 in this process. These findings have dif-
ferent contributions to our understanding of this receptor in the synergy between Mtb and distinct
retroviral infections, and also for TNT biology in host-pathogen interactions.
Our global transcriptomic approach revealed the up-regulation of Siglec-1, as part of an ISG-sig-
nature enhanced in macrophages exposed to a TB-associated microenvironment. Although pulmo-
nary active TB has been characterized as an IFN-I-driven disease (Berry et al., 2010; McNab et al.,
2015; Moreira-Teixeira et al., 2018), there are no report in the literature about a role for Siglec-1 in
TB or in Mtb co-infection with retroviruses. Expression of Siglec-1 is restricted to myeloid cells
except circulating monocytes (Crocker et al., 2007), and is enhanced by IFN-I (Puryear et al., 2013;
Rempel et al., 2008) and during HIV-1 infection (Pino et al., 2015). In addition, human alveolar mac-
rophages are distinguished from lung interstitial macrophages by Siglec-1 expression (Yu et al.,
2016). In this study, we determined that IFN-I present in TB-associated environment is responsible
for Siglec-1 overexpression in human macrophages, which resembled that obtained in HIV-1-infected
cells. While we saw a modest induction of Siglec-1 in macrophages upon IL-10 treatment, its deple-
tion from the TB-associated microenvironment had no effect on Siglec-1 expression. This could be
explained by the fact that IL-10 induces the autocrine production of IFN-I (Ziegler-Heitbrock et al.,
2003) to indirectly modulate Siglec-1 expression in M(IL-10) macrophages, which then contributes to
the exacerbation of HIV-1 infection as we previously reported (Souriant et al., 2019). In the context
of the most closely related lentivirus to HIV, namely SIV, we not only confirmed the presence of
Siglec-1+ alveolar macrophages in SIV-infected NHP, but also reported the high abundance of these
cells in active TB and in co-infected NHP groups, when compared to healthy ones. Importantly, we
associated the high abundance of Siglec-1+ leukocytes with the increase NHP pathological scores,
and it correlated positively to the detection of pSTAT1+ macrophage nuclei in histological staining
of serial sections of lung biopsies from co-infected NHP. This is in line with a recent report on the
Figure 3 continued
Scale bar, 20 mm. (B) Vertical bar plot showing the semi-automatic quantification of Siglec-1+ TNT (black) and Siglec-1- TNT (white) in thick (WGA+,
MT+) and thin (WGA+, MT-) TNT. 400 TNT were analyzed from two independent donors. (C) Siglec-1+ TNT exhibit a larger length index. Violin plots
displaying the semi-automatic quantification of TNT length (in mm) for thin (WGA+, MT-), and thick TNT (WGA+, MT+) expressing Siglec-1 or not. 400
TNT were analyzed per condition from two independent donors. (D) Representative immunofluorescence images of cmMTB-treated macrophages 3
day post-infection with HIV-1-NLAD8-VSVG strain, and stained for extracellular Siglec-1 (red), intracellular HIV-1Gag (green) and WGA (grey). Scale bar,
10 mm. (E) Vertical bar plots indicating the quantification of presence (dark grey) or absence (light grey) of HIV-1Gag in thick TNT (WGA
+, MT+)
expressing Siglec-1 or not. 120 TNT in at least 1000 cells were analyzed from four independent donors. (F) Representative immunofluorescence images
of cmMTB-treated macrophages infected with HIV-1-ADA loaded with MitoTracker (MitoT, green), and stained for extracellular Siglec-1 (red) and WGA
(grey). Inserts are 3x zooms. Green arrowheads show mitochondria inside TNT. Scale bar, 10 mm. Statistical analyses: Two-way ANOVA comparing the
presence of Siglec-1 in thin and thick TNT (B), and two-tailed Mann-Whitney unpaired test comparing TNT length (C) and the presence of HIV-1 in TNT
(E). *p<0.05, ****p<0.0001. See Figure 3—source data 1.
The online version of this article includes the following video, source data, and figure supplement(s) for figure 3:
Source data 1. Raw data and statistical analyses supporting Siglec-1 expression on thick TNT and its correlation with TNT length.
Figure supplement 1. Siglec-1 localizes specifically on thick tunneling nanotubes that contain HIV-1Gag and mitochondria.
Figure 3—video 1. Related to Figure 3A.
https://elifesciences.org/articles/52535#fig3video1
Figure 3—video 2. Related to Figure 3D.
https://elifesciences.org/articles/52535#fig3video2
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Figure 4. The exacerbation of HIV-1 infection and spread in macrophages treated with cmMTB requires Siglec-1. (A) Experimental design. Monocytes
from healthy subjects were transfected with siRNA targeting of Siglec-1 (siSiglec-1, black) or not (siCtrl, white). A day after, monocytes were
differentiated into macrophages with cmMTB for 3 days. Cells were then infected with HIV-1-ADA (blue protocol) to measure the formation (B) and
length (C) of TNT at day 7, or assess HIV-1 production and multinucleated giant cell (MGC) formation at day 14 (F–G). In parallel, cells were either
infected with HIV-NLAD8-VSVG or labelled with mitoTracker to measure the transfer (red protocol) of HIV-1 (D) or mitochondria (E), respectively. (B)
Before-and-after plots showing the percentage of cells forming thick TNT (F-actin+, WGA+, MT+). (C) Violin plots displaying the semi-automatic
quantification of TNT length (in mm) for thick (WGA+, MT+) TNT; 300 TNT were analyzed per condition from two independent donors. (D–E) Before-
and-after plots indicating the percentage of HIV-1Gag
+ cells (D) or MitoTracker+ cells (E) among CellTracker+ cells after 24 hr co-culture. (F)
Representative immunofluorescence images of siRNA transfected cells treated with cmMTB, 14 days post-HIV-1 infection. Cells were stained for
intracellular HIV-1Gag (green), F-actin (red) and DAPI (blue). Scale bar, 500 mm. (G) Vertical scatter plots showing HIV-1-p24 concentration in cell
supernatants (upper panel) and percentage of MGC (lower panel) at day 14 post-HIV-1 infection in cells represented in F (siSiglec-1, black; siCtrl, white).
(B, D, E and G) Each circle represents a single donor and histograms median value. Statistical analyses: Paired t-test (B, G lower panel) or two-tailed,
Wilcoxon signed-rank test (C-E, G upper panel). *p<0.05, **p<0.01, ****p<0.0001. See Figure 4—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Raw data and statistical analyses supporting a role for Siglec-1 in TNT length, HIV-1 and mitochondrial cell-to-cell trasfer, and exacerba-
tion of HIV-1 infection.
Figure supplement 1. Siglec-1 is required for the capture and transfer of HIV-1 in cmMTB-treated macrophages.
Figure supplement 1—source data 1. Supplemental raw data and statistical analyses supporting the functional role of Siglec-1 in human macrophages
using an siRNA-mediated gene silencing approach.
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presence of IFN-I, IFNAR and different ISG in alveolar and lung interstitial tissue from NHP with
active TB (Mattila, 2019), and with the fact that the in vivo expression of Siglec-1 is up-regulated
early in myeloid cells after SIV infection and maintained thereafter in the pathogenic NHP model
(Jaroenpool et al., 2007). In TB-SIV co-infection, we hypothesized that IFN-I is not exerting the
expected antiviral effect, but instead is concomitant with chronic immune activation and attenuated
by the high expression of Siglec-1 in myeloid cells, as recently proposed in the HIV-1 context
(Akiyama et al., 2017). Altogether, these findings uncover the IFN-I/STAT1/Siglec-1 axis as a mech-
anism established by Mtb to exacerbate HIV-1 infection in myeloid cells, and call for the need to fur-
ther investigate this signaling pathway in TB pathogenesis.
Another aspect worth highlighting is the impact that Siglec-1 expression has in the capture and
transfer of HIV-1 by M(IL-10) macrophages, in particular in the context of TNT. First, we reported
that Siglec-1 is located on MT-positive thick (and not on thin) TNT, correlating positively with
increased length and HIV-1 cargo. To our knowledge, no receptor has been described so far to be
present mainly on thick TNT, making Siglec-1 an unprecedented potential marker for this subtype of
TNT (Dupont et al., 2018). Second, viral uptake assays demonstrated the functional capacity of
Siglec-1, including on thick TNT, to interact with viral-like particles bearing sialylated lipids; loss-of-
function approaches showed Siglec-1 is important in the capture of these viral particles. Third,
Siglec-1 depletion correlated with a decrease in thick TNT length, but had no effect in the total num-
ber of thick TNT. This suggests that, while the IFN-I/STAT1 axis is responsible for Siglec-1 expression
in M(IL-10) macrophages, it does not contribute to TNT formation. This is line with our previous
report where TNT formation induced by TB-associated microenvironments depended on the IL-10/
STAT3 axis (Souriant et al., 2019). Concerning the shortening of thick TNT length, we infer that it
may reflect a fragile state due to an altered cell membrane composition in the absence of Siglec-1;
TNT are known for their fragility towards light exposure, shearing force and chemical fixation
(Rustom et al., 2004). We hypothesize that the longer the TNT is, the more rigidity it requires to be
stabilized. Cholesterol and lipids are known to increase membrane rigidity (Redondo-Morata et al.,
2012) and are thought to be critical for TNT stability (Lokar et al., 2012; Thayanithy et al., 2014).
Thus, the presence of Siglec-1 in thick TNT may affect the cholesterol and lipid composition via the
recruitment of GM1/GM3 glycosphingolipid-enriched microvesicles (Halász et al., 2018). In fact,
TNT formation depends on GM1/GM3 ganglioside and cholesterol content (Kabaso et al., 2011;
Lokar et al., 2012; Osteikoetxea-Molnár et al., 2016; Tóth et al., 2017). Since GM1 and GM3 gly-
cosphingolipids are bona fide ligands for Siglec-1 (Puryear et al., 2013), it is likely that Siglec-1+
thick TNT exhibit a higher lipid and cholesterol content, and hence an increase of membrane rigidity
that favors the stability of longer TNT. Fourth, Siglec-1-depleted donor macrophages were less
capable to transfer HIV-1, and to some extend mitochondria, to recipient cells. While infectious syn-
apse and exososome release are mechanisms attributed to Siglec-1 that contribute to cell-to-cell
transfer of HIV-1 (Bracq et al., 2018; Gummuluru et al., 2014; Izquierdo-Useros et al., 2014), they
accomplish so extracellularly. Here, we speculate that Siglec-1 participates indirectly in the intracellu-
lar HIV-1 transfer via TNT as a tunnel over long distance, suggesting that factors affecting TNT rigid-
ity favor distal viral dissemination while ensuring protection against immune detection. Independent
of HIV-1 infection, we also noticed that cmMTB-treated cells depleted for Siglec-1 displayed a
decreasing tendency to transfer mitochondria among them. As TNT-transferred mitochondria are
known to alter the metabolism and functional properties of recipient cells under steady state condi-
tions or in the cancer context, it implies that Siglec-1 may also influence key metabolic pathways
such as glycolysis, pentose phosphate and lipid metabolism, among others (Hekmatshoar et al.,
2018). This is important because, for example, the gain of cancer drug resistance is directly associ-
ated to TNT-mediated mitochondria transfer, thus Siglec-1 may represent a novel therapeutic strat-
egy to overcome cancer cell drug resistance. Finally, the depletion of Siglec-1 abrogated the
exacerbation of HIV-1 infection and production induced by TB in M(IL-10) macrophages. This is likely
to result from an accumulative effect of deficient capture and transfer of HIV-1 in the absence of
Siglec-1. However, these results do not discern the specific contribution of Siglec-1 to the cell-to-cell
transmission of HIV-1 via TNT from that obtained through other mechanisms (Bracq et al., 2018).
Future studies will address whether the contribution of Siglec-1 to cell-to-cell transfer mechanisms
has an impact in Mtb dissemination (Onfelt et al., 2006).
In conclusion, our study identifies Siglec-1 as a key factor involved in the exacerbation of HIV-1
infection in macrophages conditioned by cmMTB. It is worth noting that we have previously
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reported that a loss-of-function variant in Siglec-1 in the human population does not conclusively
establish a role for this receptor in AIDS progression, even though ex vivo experiments demon-
strated that cells from these individuals were functionally null or partially defective for Siglec-1
expression along with poor HIV-1 capture and transmission (Martinez-Picado et al., 2016). While
this may be counterintuitive for proposing Siglec-1 as a therapeutic target to limit viral dissemination
in the co-infection context, there are several challenges to the study of Siglec-1 variants, such as lim-
ited cohort size, the lack of complete clinical records, and the restriction to study only off-therapy
periods, among others (Martinez-Picado et al., 2017). Therefore, there is a strong need for future
work targeting Siglec-1 to unveil its in vivo contribution of the mononuclear phagocyte system to
HIV-1 pathogenesis to fully exploit the therapeutic potential of this receptor. Beyond the infectious
disease context, our study also sheds light on a new homeostatic function for Siglec-1 in human mac-
rophages, such as intercellular communication facilitated by TNT. We argue that Siglec-1 localization
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M-CSF Peprotech Cat# 30025 (20 ng/mL)
Cytokine
(recombinant, human)
IFNb Peprotech Cat# 300-02BC 10 and 100 U/mL
Cytokine
(recombinant, human)
IL-10 Peprotech Cat# 200-10 10 ng/mL
Monocyte isolation Mouse antihuman
CD14 microbeads
Miltenyi Biotec Cat# 130050201
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Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Monocyte isolation LS magnetic columns Miltenyi Biotec Cat# 130042401
Western blot Amersham ECL Prisme
Western Blotting
Detection Reagent




Thermo Scientific Cat# 34080
ELISA IL10 ELISA set BD Bioscience Cat# 555157
Cell culture Trypsin
EDTA 0.05%
Thermo Fisher Scientific Cat# 25200072
Cell culture Accutase Sigma-Aldrich Cat# A-6964
Probe Phalloidin
AlexaFluor 488
Thermo Fisher Scientific Cat# A12379 (33 mM)
Probe Phalloidin
Alexa Fluor 647
Thermo Fisher Scientific Cat# A22287 (33 mM)
Probe DAPI Sigma Aldrich Cat# D9542 (500 ng/mL)
Probe CellTracker Green
CMFDA Dye
Thermo Fisher Scientific Cat# C7025 (500 ng/mL)
Probe MitoTracker
Deep Red FM
Invitrogen Cat# M22426 (500 ng/mL)
IF Fluorescence
Mounting Medium






Software ImageJ ImageJ http://www.imagej.nih.gov/ij
Software Prism (v8.0.0) GraphPad http://www.graphpad.com
Software Photoshop CS3 Adobe http://www.adobe.com








Software FACS DIVA BD Bioscience http://www.bdbiosciences.com/
Software FlowJo_v10 FlowJo https://www.flowjo.com/
Software FCS Express V3 DeNovo Software http://www.denovosoftware.com
Software Image Lab BioRad Laboratories http://www.biorad.com
Software Pannoramic Viewer 3DHISTECH https://www.3dhistech.
com/pannoramic_viewer
Human subjects
Monocytes from healthy subjects were provided by Etablissement Français du Sang (EFS), Toulouse,
France, under contract 21/PLER/TOU/IPBS01/20130042. According to articles L12434 and R124361
of the French Public Health Code, the contract was approved by the French Ministry of Science and
Technology (agreement number AC 2009921). Written informed consents were obtained from the
donors before sample collection.
Non-Human primate (NHP) samples
All animal procedures were approved by the Institutional Animal Care and Use Committee of Tulane
University, New Orleans, LA and were performed at the Tulane TNPRC, and under approval from
IACUC (project numbers P3733, P3794, P3373 and P3628). They were performed in strict accor-
dance with NIH guidelines. The twenty adult rhesus macaques used in this study
(Supplementary file 1-Table S1 and S2) were bred and housed at the Tulane National Primate
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Research Center (TNPRC). All macaques were infected as previously described (Foreman et al.,
2016; Mehra et al., 2011; Souriant et al., 2019). Briefly, aerosol infection was performed on maca-
ques using a low dose (25 CFU implanted) of Mtb CDC1551. Nine weeks later, a subgroup of the
animals was additionally intravenously injected with 300 TCID50 of SIVmac239 in 1 mL saline, while
controls received an equal volume of saline solution. Euthanasia criteria were presentation of four or
more of the following conditions: (i) body temperatures consistently greater than 2 ˚F above pre-
infection values for three or more weeks in a row; (ii) 15% or more loss in body weight; (iii) serum
CRP values higher than 10 mg/mL for three or more consecutive weeks, CRP being a marker for sys-
temic inflammation that exhibits a high degree of correlation with active TB in macaques
(Kaushal et al., 2012; Mehra et al., 2011); (iv) CXR values higher than two on a scale of 0–4; (v)
respiratory discomfort leading to vocalization; (vi) significant or complete loss of appetite; and (vii)
detectable bacilli in BAL samples.
Bacteria
Mtb H37Rv strain was grown in suspension in Middlebrook 7H9 medium (Difco) supplemented with
10% albumin-dextrose-catalase (ADC, Difco) and 0.05% Twen-80 (Sigma-Aldrich) (Lastrucci et al.,
2015). For infection, growing Mtb was centrifuged (3000 rpm) at exponential phase stage and resus-
pended in PBS (MgCl2, CaCl2 free, Gibco). Twenty passages through a 26 G needle were done for
dissociation of bacterial aggregates. Bacterial suspension concentration was then determined by
measuring OD600, and then resuspended in RPMI-1640 containing 10% FBS for infection.
Viruses
Virus stocks were generated by transient transfection of 293 T cells with proviral plasmids coding for
HIV-1 ADA and HIV-1 NLAD8-VSVG isolates, kindly provided by Serge Benichou (Institut Cochin,
Paris, France), as previously described (Vérollet et al., 2015). Supernatant were harvested 2 days
post-transfection and HIV-1 p24 antigen concentration was assessed by a homemade enzyme-linked
immunosorbent assay (ELISA). HIV-1 infectious units were quantified, as reported (Souriant et al.,
2019) using TZM-bl cells (NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH from Dr. John
C. Kappes, Dr. Xiaoyun Wu and Tranzyme Inc).
HIV-VLP stock (GFP VLP) was generated by transfecting the molecular clone pGag-eGFP obtained
from the NIH AIDS Research and Reference Reagent Program. HEK-293 T cells were transfected
with calcium phosphate (CalPhos, Clontech) in T75 flasks using 30 mg of plasmid DNA. Supernatants
containing VLP were filtered (Millex HV, 0.45 mm; Millipore) and frozen at  80˚C until use. The p24
Gag content of the VLP was determined by an ELISA (Perkin-Elmer).
Preparation of human monocytes and monocyte-derived macrophages
Human monocytes were isolated from healthy subject (HS) buffy coat (from EFS) and differentiated
towards macrophages as described (Souriant et al., 2019). Briefly, peripheral blood mononuclear
cells (PBMC) were recovered by gradient centrifugation on Ficoll-Paque Plus (GE Healthcare). CD14+
monocytes were then isolated by positive selection magnetic sorting, using human CD14 Microbe-
ads and LS columns (Miltenyi Biotec). Cells were then plated at 1.6  106 cells per 6-well and
allowed to differentiate for 5–7 days in RPMI-1640 medium (GIBCO), 10% Fetal Bovine Serum (FBS,
Sigma-Aldrich) and human M-CSF (20 ng/mL) Peprotech) before infection with Mtb H37Rv for condi-
tioned-media preparation. The cell medium was renewed every 3 or 4 days.
Preparation of conditioned media
Conditioned-media from Mtb-infected macrophages (cmMTB) has been reported previously
(Lastrucci et al., 2015; Souriant et al., 2019). Succinctly, hMDM were infected with Mtb H37Rv at a
MOI of 3. After 18 hr of infection at 37˚C, culture supernatants were collected, sterilized by double
filtration (0.2 mm pores) and aliquots were stored at  80˚C. We then tested the capacity of individual
cmMTB to differentiate freshly isolated CD14+ monocytes towards the M(IL-10) cell-surface marker
phenotype, as assessed by FACS analyses. Those supernatants yielding a positive readout were then
pooled together (5–10 donors) to minimize the inter-variability obtained between donors. Control
media (cmCTR) was obtained from uninfected macrophage supernatant. When specified, IL-10 was
eliminated from cmMTB by antibody depletion as described previously (Lastrucci et al., 2015;
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Souriant et al., 2019). The depletion was verified by ELISA (BD-Bioscience), according to manufac-
turer’s protocol.
Conditioning of monocytes with the secretome of Mtb-infected
macrophages or cytokines
Human CD14+ sorted monocytes from HS buffy coat were allowed to adhere in the absence of
serum (0.4  106 cells / 24-well in 500 mL) on glass coverslips, and then cultured for 3 days with 40%
dilution (vol/vol) of cmCTR or cmMTB supplemented with 20% FBS and M-CSF (20 ng/mL, Pepro-
tech). Blocking IFNAR receptor was performed by pre-incubation with mouse anti-IFNAR antibody
(20 mg/mL, Thermo Fischer Scientific) in a 200 mL for 30 min prior to conditioning. After 3 days, cells
were washed and collected for phenotyping.
When specified, monocytes were also conditioned in presence of 20 ng/mL M-CSF and 10 ng/mL
recombinant human IL-10 (PeproTech) or 10 U/mL of IFNb (Peprotech). Cell-surface expression of
Siglec-1 was measured by flow cytometry using standard procedures detailed hereafter.
RNA extraction and transcriptomic analysis
Cells conditioned with cmCTR and cmMTB supernatants (approximately 1.5 million cells) were
treated with TRIzol Reagent (Invitrogen) and stored at  80˚C. Total RNA was extracted from the TRI-
zol samples using the RNeasy mini kit (Qiagen). RNA amount and purity (absorbance at 260/280 nm)
was measured with the Nanodrop ND-1000 apparatus (Thermo Scientific). According to the manu-
facturer’s protocol, complementary DNA was then reverse transcribed from 1 mg total RNA with
Moloney murine leukemia virus reverse transcriptase (Invitrogen), using random hexamer oligonu-
cleotides for priming. The microarray analysis was performed using the Agilent Human GE 4  44 v2
(single color), as previously described (Lugo-Villarino et al., 2018). Briefly, we performed hybridiza-
tion with 2 mg Cy3-cDNA and the hybridization kit (Roche NimbleGen). The samples were then incu-
bated for 5 min at 65˚C, and 5 min at 42˚C before loading for 17 hr at 42˚C, according to
manufacturer’s protocol. After washing, the microarrays were scanned with MS200 microarray scan-
ner (Roche NimbleGen), and using Feature Extraction software, the Agilent raw files were extracted
and then processed through Bioconductor (version 3.1) in the R statistical environment (version
3.6.0). Using the limma package, raw expression values were background corrected in a ‘normexp’
fashion and then quantile normalized and log2 transformed (Ritchie et al., 2015). Density plots, box-
plots, principal component analyses, and hierarchical clustering assessed the quality of the hybridiza-
tions. Differentially expressed genes between macrophages exposed to cmCTR or cmMTB
supernatants were extracted based on the p-value corrected using the Benjamini-Hochberg proce-
dure. The log2 normalized expression values were used to perform Gene Set Enrichment Analyses
(GSEA). The GSEA method allows to statistically test whether a set of genes of interest (referred to
as a geneset) is distributed randomly or not in the list of genes that were pre-ranked according to
their differential expression ratio between macrophages exposed to cmCTR or cmMTB supernatants.
The output of GSEA is a GeneSet enrichment plot. The vertical black lines represent the projection
onto the ranked GeneList of the individual genes of the GeneSet. The top curve in green corre-
sponds to the calculation of the enrichment score (ES). The more the ES curve is shifted to the upper
left of the graph, the more the GeneSet is enriched in the red cell population. Conversely, the more
the ES curve is shifted to the lower right of the graph, the more the GeneSet is enriched in the blue
cell population.
siRNA silencing
Targeted gene silencing in monocytes was performed using reverse transfection protocol as previ-
ously described (Troegeler et al., 2014). Shortly, human primary monocytes were transfected with
200 nM of ON-TARGETplus SMARTpool siRNA targeting Siglec-1 (Horizon Discovery) or non-target-
ing siRNA (control) using HiPerfect transfection system (Qiagen). After a four-hr post-transfection,
cells were allowed to rest for 24 hr in RPMI-1640 medium, 10% FBS, 20 ng/mL of M-CSF, before
addition of cmMTB media (40% vol/vol). After three additional days of conditioning, cells were
infected with HIV-1 ADA or HIV-1- NLAD8-VSV-G strain, and kept in culture for 10 more days or 48
hrs, respectively. Validation of gene silencing was done after three days post-transfection, and this
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protocol led to the efficient depletion of Siglec-1 ranging between 50 to95%, as measured by flow
cytometry.
HIV-1 infection
For HIV-1 infection, at day 3 of differentiation, 0.4  106 human monocytes-derived macrophages
(hMDM) were infected with HIV-1 ADA strain (or as indicated otherwise) at MOI 0.1. HIV-1 infection,
and replication were assessed at 10-day post-infection by measuring p24-positive cells by immunos-
taining and the level of p24 released in culture media by ELISA. For the infection and TNT quantifica-
tion at day six post-infection, the same protocol was used. For HIV-1 transfer, higher MOI of HIV-1
VSVG pseudotyped NLAD8 virus was used, as described below (see section HIV-1 and cell-to-cell
transfer) and in Souriant et al. (2019).
Uptake of Virus-Like particles
Uptake experiment were performed as previously described (Izquierdo-Useros et al., 2012a;
Izquierdo-Useros et al., 2014; Pino et al., 2015) using p24Gag HIV-1Gag eGFP VLP (GFP VLP). Briefly,
monocytes transfected (or not) with control siRNA, or with siRNA directed against Siglec-1, and dif-
ferentiated for 3 days in cmCTR or cmMTB, were washed once with PBS prior to addition of 2 ng/
mL of GFP VLP. Binding was performed during 3.5 hr at 37˚C in a 5% CO2 incubator. Cells were then
detached with cell dissociation buffer (Gibco) and prepared for flow cytometry analysis on a BD
LSRFortessa (TRI-Genotoul platerform). Same experiment was also performed blocking monocyte-
derived macrophages at RT for 15 min with 10 mg/mL of mAb a-Siglec-1 7–239 (Abcam), IgG1 iso-
type control (BD Biosciences) or leaving cells untreated before VLP addition.
Flow cytometry and Siglec-1 quantitation
Staining of conditioned macrophages was performed as previously described (Souriant et al.,
2019). Adherent cells were harvested after 5 min incubation in trypsin 0.05% EDTA (Gibco) and
washes with PBS (Gibco). After 10 min centrifugation at 320 g, pellets were resuspended in cold
staining buffer (PBS, 2 mM EDTA, 0.5% FBS) with fluorophore-conjugated antibodies (See Key
ressources Table) and, in parallel, with the corresponding isotype control antibody using a general
concentration of 1 mg/mL. After staining, cells were washed with cold staining buffer, centrifuged for
2 min at 320 g at 4˚C, and analyzed by flow cytometry using BD LSRFortessa flow cytometer (BD Bio-
sciences, TRI Genotoul plateform) and the associated BD FACSDiva software. Data were then ana-
lyzed using the FlowJo_V10 software (FlowJo, LLC). Gating on macrophage population was set
according to its Forward Scatter (FSC) and Size Scatter (SSC) properties before doublet exclusion
and analysis of the median fluorescence intensity (MFI) for each staining.
To determine Siglec-1 expression, we applied a quantitative FACS assay. Briefly, cmCTR- and
cmMTB-treated macrophages were detached using Accutase solution (Gibco) for 10 min at 37˚C,
washed, blocked with 1 mg/mL human IgG (Privigen, Behring CSL), and stained with mAb 7–239 a-
Siglec-1-PE or matched isotype-PE control (Biolegend) at 4˚C for 30 min. The mean number of
Siglec-1 mAb binding sites per cell was obtained with a Quantibrite kit (Becton Dickinson) as previ-
ously described (Izquierdo-Useros et al., 2012b). Samples were analyzed with FACSCalibur using
CellQuest software to evaluate collected data.
Immunofluorescence microscopy
Cells were fixed with PFA 3.7%, Sucrose 30 mM in PBS. After washing with PBS, cells were saturated
with blocking buffer (PBS-BSA 1%). Depending on the experiments, cells were permeabilized as pre-
viously described (Souriant et al., 2019) with Triton X-100 0.3% for 10 min (or not), and then stained
for 2 hrs with the primary antibody: anti-Siglec-1 (10 mg/mL, Novus Biologicals). Cells were then incu-
bated with appropriate secondary antibodies for 1 hr: Alexa Fluor 488 or 555 or 647 Goat anti-
Mouse IgG (2 mg/mL, Cell Signaling Technology). Cells were then permeabilized, washed in PBS
before saturation with 0.6 mg/mL mouse IgG2 diluted in Dako Antibody Reducing Background buffer
(Dako) for 30 min. Intracellular proteins were then stained with anti-Gag KC57 RD1 antibody (1/100,
Beckman Coulter) and/or anti-a-tubulin (5 mg/mL, Abcam) for 2 hrs. Cells were washed and finally
incubated with Alexa Fluor 488, 555 or 647 Goat anti-Mouse, or Goat anti-Rabbit IgG secondary
antibodies (2 mg/mL, Cell Signaling Technology), Alexa Fluor 488 or 555 Phalloidin (33 mM, Thermo
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Fisher Scientific), Wheat Germ Agglutinin (CF350 WGA, Thermofischer) and DAPI (500 ng/mL, Sigma
Aldrich) in blocking buffer for 1 hr. Coverslips were mounted on a glass slide using Fluorescence
Mounting Medium (Dako) and visualized with a spinning disk (Olympus), a Zeiss confocal LSM880
with Airyscan or a FV1000 confocal microscope (Olympus).
TNT were identified by WGA or phalloidin and tubulin staining, and counted on at least 1000 cells
per condition and per donor.
As HIV-1 infection induces macrophages fusion into MGC (Vérollet et al., 2010), the number of
infected cells largely underestimates the rate of infection. Thus, to better reflect the rate of infection,
we quantified the percentage of MGC. Using semi-automatic quantification with homemade Image J
macros, allowing the study of more than 5,000 cells per condition in at least five independent
donors, we assessed these parameters.
HIV-1 and cell-to-cell transfer
Freshly isolated CD14+ monocytes from HS transfected with siRNA against Siglec-1 (or siRNA con-
trol) were allowed to adhere in the absence of serum (2  106 cells/6-well in 1.5 mL). After 4 hr of
culture, RPMI-1640 supplemented with 20 ng/mL M-CSF and 20% FBS were added to the cells (vol/
vol). After 24 hr, cells were conditioned with cmMTB media. At day 4, 120 ng p24 of a HIV-1 NLAD8
strain pseudotyped with a VSVG envelope was used to infect half of the cells, kept in culture for two
more days. At day 6, before co-culture, uninfected cells were stained with CellTracker Green
CMFDA Dye (Thermo Fisher Scientific). For mitochondria transfer, half of the macrophages were
pre-stained with Green CellTracker, and the other half, uninfected, was stained with mitoTracker
Deep-Red prior to co-culture. Briefly, cells were washed with PBS Mg2+/Ca2+ and stained for 30 min
with 500 ng/mL CellTracker or mitoTracker, before washing with RPMI-1640 10% FBS. HIV-1+(or
mitoTracker+) and CellTracker+ cells were then detached using accutase (Sigma) and co-cultured at
a 1:1 ratio on glass coverslips in 24-well.
Histological analyses
Paraffin embedded tissue samples were sectioned and stained with hematoxylin and eosin for histo-
morphological analysis. Different antigen unmasking methods where used on tissue slides for immu-
nohistochemical staining, which was performed using anti-CD163 (Leica/Novocastra), anti-Siglec-1
(Novus Biologicals) and anti-pSTAT1 (Cell Signaling Technology). Sections were then incubated with
biotin-conjugated polyclonal anti-mouse or anti-rabbit immunoglobulin antibodies, followed by the
streptavidin-biotin-peroxidase complex (ABC) method (Vector Laboratories). Finally, sections were
counter-stained with hematoxylin. Slides were scanned with the Panoramic 250 Flash II (3DHISTECH).
Virtual slides were automatically quantified for macrophage distribution as previously described
(Souriant et al., 2019). Immunofluorescence staining of the sections was performed as described
above, and followed by anti-mouse IgG isotype specific or anti-rabbit IgG antibodies labelled with
Alexa488 and Alexa555 (Molecular Probes). Samples were mounted with Prolong Antifade reagent
(Molecular Probes) and examined using a 60x/1.40N.A. objective of an Olympus spinning disk
microscope.
Quantification and statistical analysis
Information on the statistical tests used and the exact values of n (donors) can be found in the Figure
Legends. All statistical analyses were performed using GraphPad Prism 8.0.0 (GraphPad Software
Inc). Two-tailed paired or unpaired t-test was applied on data sets with a normal distribution (deter-
mined using Kolmogorov-Smirnov test), whereas two-tailed Mann-Whitney (unpaired test) or Wil-
coxon matched-paired signed rank tests were used otherwise. p<0.05 was considered as the level of
statistical significance (*p0.05; **p0.005; ***p0.0005; ****p0.0001).
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Nyitrai M, Matkó J, Szabó-Meleg E. 2018. Live cell superresolution-structured illumination microscopy imaging
analysis of the intercellular transport of microvesicles and costimulatory proteins via nanotubes between
immune cells. Methods and Applications in Fluorescence 6:045005. DOI: https://doi.org/10.1088/2050-6120/
aad57d, PMID: 30039805
Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. 2001. Characterization of human sialoadhesin, a
sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97:288–
296. DOI: https://doi.org/10.1182/blood.V97.1.288
Hashimoto M, Bhuyan F, Hiyoshi M, Noyori O, Nasser H, Miyazaki M, Saito T, Kondoh Y, Osada H, Kimura S,
Hase K, Ohno H, Suzu S. 2016. Potential role of the formation of tunneling nanotubes in HIV-1 spread in
macrophages. The Journal of Immunology 196:1832–1841. DOI: https://doi.org/10.4049/jimmunol.1500845,
PMID: 26773158
Hekmatshoar Y, Nakhle J, Galloni M, Vignais ML. 2018. The role of metabolism and tunneling nanotube-
mediated intercellular mitochondria exchange in Cancer drug resistance. Biochemical Journal 475:2305–2328.
DOI: https://doi.org/10.1042/BCJ20170712, PMID: 30064989
Honeycutt JB, Wahl A, Baker C, Spagnuolo RA, Foster J, Zakharova O, Wietgrefe S, Caro-Vegas C, Madden V,
Sharpe G, Haase AT, Eron JJ, Garcia JV. 2016. Macrophages sustain HIV replication in vivo independently of T
cells. Journal of Clinical Investigation 126:1353–1366. DOI: https://doi.org/10.1172/JCI84456, PMID: 26950420
Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD,
Garcia JV. 2017. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral
therapy. Nature Medicine 23:638–643. DOI: https://doi.org/10.1038/nm.4319, PMID: 28414330
Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nature Reviews Immunology 14:36–49.
DOI: https://doi.org/10.1038/nri3581, PMID: 24362405
Izquierdo-Useros N, Lorizate M, Contreras FX, Rodriguez-Plata MT, Glass B, Erkizia I, Prado JG, Casas J, Fabriàs
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and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLOS
Pathogens 10:e1004146. DOI: https://doi.org/10.1371/journal.ppat.1004146, PMID: 25033082
Jambo KC, Banda DH, Kankwatira AM, Sukumar N, Allain TJ, Heyderman RS, Russell DG, Mwandumba HC.
2014. Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function.
Mucosal Immunology 7:1116–1126. DOI: https://doi.org/10.1038/mi.2013.127, PMID: 24472847
Jaroenpool J, Rogers KA, Pattanapanyasat K, Villinger F, Onlamoon N, Crocker PR, Ansari AA. 2007. Differences
in the constitutive and SIV infection induced expression of siglecs by hematopoietic cells from non-human
primates. Cellular Immunology 250:91–104. DOI: https://doi.org/10.1016/j.cellimm.2008.01.009, PMID: 1
8331725
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I, Kellermayer M, Yamaji T, Hanada K, Vı́gh L, Matkó J. 2017. Nanotubes connecting B lymphocytes: high
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